Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease

scientific article published in January 2009

Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/08860220802599106
P698PubMed publication ID19212906

P50authorVivekanand JhaQ38800410
Madhu KhullarQ43057402
P2093author name stringVinay Sakhuja
Krishan Lal Gupta
Anirban Ganguli
Harbir Singh Kohli
P2860cites workAssay for lipid peroxides in animal tissues by thiobarbituric acid reactionQ29616762
Role of oxidative modifications in atherosclerosisQ29617974
The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremiaQ34952514
Acute injury with intravenous iron and concerns regarding long-term safetyQ36910507
Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injuryQ40721786
Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivoQ43910618
Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammationQ44198980
Comparison of injectable iron complexes in their ability to iron load tissues and to induce oxidative stressQ44393674
The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.Q44440182
The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failureQ44846324
Transferrin saturation with intravenous irons: an in vitro studyQ45028937
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.Q50709357
P433issue2
P304page(s)106-110
P577publication date2009-01-01
P1433published inRenal FailureQ15762963
P1476titleLipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease
P478volume31